Advertisement
GKOS Nov 2024 100.000 call
OPR - OPR Delayed Price. Currency in USD
Follow
At close: 01:12PM EDT
| Previous Close | 30.64 |
| Open | 30.64 |
| Bid | 30.10 |
| Ask | 34.40 |
| Strike | 100.00 |
| Expire Date | 2024-11-15 |
| Day's Range | 30.64 - 30.64 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 4 |
ZacksGKOS Stock Rises on Positive Phase 3 Confirmatory Trial for Epioxa
Glaukos announces positive second Phase 3 confirmatory pivotal trial for Epioxa.
Pharmaceutical TechnologyGlaukos eyes FDA approval for ocular therapy after Phase III win
The company’s keratoconus medication, Epioxa, was effective in a Phase III trial, with plans to file for submission with the US Food and Drug Administration (FDA).
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.